Hester Biosciences Ltd.
BSE: 524669 | Sector: Health care |
NSE: HESTERBIO | ISIN Code: INE782E01017 |
BSE 00:00 | 13 Apr | 2019.60 |
29.95 (1.51%) |
OPEN
2025.05 |
HIGH
2073.45 |
LOW
1982.00 |
NSE 00:00 | 13 Apr | 2016.75 |
25.15 (1.26%) |
OPEN
2007.55 |
HIGH
2075.00 |
LOW
1979.85 |
OPEN | 2025.05 |
PREVIOUS CLOSE | 1989.65 |
VOLUME | 2144 |
52-Week high | 2279.80 |
52-Week low | 960.00 |
P/E | 47.67 |
Mkt Cap.(Rs cr) | 1,719 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Hester Biosciences Ltd. (HESTERBIO) - Yearly Result
Particulars (![]() |
Mar '20 | Mar '19 | Mar '18 | Mar '17 | Mar '16 |
Net Sales/Income From Operations | 169.43 | 171.19 | 134.79 | 123.28 | 100.89 |
Other Income | 2.93 | 3.10 | 1.88 | 0.73 | 0.87 |
Total Income | 172.35 | 174.28 | 136.66 | 124.01 | 101.76 |
Total Expenditure | 116.71 | 103.42 | 85.19 | 82.21 | 67.50 |
Operating Profit | 55.65 | 70.86 | 51.47 | 41.80 | 34.27 |
Interest | 5.03 | 3.54 | 2.32 | 3.21 | 3.69 |
Gross Profit | 50.61 | 67.32 | 49.16 | 38.60 | 30.58 |
Depreciation | 9.38 | 7.57 | 5.45 | 5.51 | 5.73 |
PBT | 41.23 | 59.75 | 43.71 | 33.08 | 24.85 |
Tax | 11.81 | 15.24 | 12.52 | 7.38 | 5.63 |
Net Profit/(Loss) | 31.22 | 43.85 | 30.56 | 24.94 | 19.22 |
Minority Interest After NP | - | - | - | - | - |
Net Profit after Minority Interest | - | - | - | - | - |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit After Exceptional Items | 31.22 | 43.85 | 30.56 | 24.94 | 19.22 |
Equity Share Capital | 8.51 | 8.51 | 8.51 | 8.51 | 8.51 |
Reserves Excluding Revaluation Reserves | 194.57 | 170.93 | 137.57 | 113.59 | 91.81 |
EPS | |||||
Basic EPS | 36.70 | 51.55 | 35.92 | 29.32 | 22.60 |
Public Share Holding | |||||
No Of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
Share Holding (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Promoters and Promoter Group Shareholding | |||||
a) Pledged/Encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of Shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of Shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
b) Non-encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Note : | PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure. |
Quick Links for Hester Biosciences:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices